Article
Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal.
Oncogene - 1 Jul 2020
Chai Tin Fan, Manu Kanjoormana Aryan, Casey Patrick J, Wang Mei
Abstract excerpt
Cancer stem cells possess the capacity for self-renewal and resistance to chemotherapy. It is therefore crucial to understand the molecular regulators of stemness in the quest to develop effective cancer therapies. TAZ is a transcription activator that promotes stem cell functions in post-development mammalian cells; suppression of TAZ activity reduces or eliminates cancer stemness in select cancers....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
